Issued Patents All Time
Showing 1–25 of 28 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12404259 | Inhibitors of extracellular signal-regulated kinase | Adam Galan, Ritu Lal, Chakk Ramesha, Paul S. Shapiro, Steven Fletcher | 2025-09-02 |
| 12202810 | Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors | Paul S. Shapiro, Jeffrey D. HASDAY, Steven Fletcher | 2025-01-21 |
| 11911393 | Non-catalytic substrate-selective p38alpha-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof | Paul S. Shapiro, Jeffrey D. HASDAY | 2024-02-27 |
| 11911392 | Non-catalytic substrate-selective p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof | Paul S. Shapiro, Jeffrey D. HASDAY | 2024-02-27 |
| 11718595 | Non-ATP/catalytic site p38 Mitogen Activated Protein Kinase inhibitors | Paul S. Shapiro, Jeffrey D. HASDAY, Steven Fletcher | 2023-08-08 |
| 11634381 | RUNX2 transcription factor inhibitors and uses thereof | Antonino Passaniti | 2023-04-25 |
| 11510908 | Protein translation inhibitors and uses thereof | France Carrier, David J. Weber, Wenbo Yu | 2022-11-29 |
| 11357781 | Non-catalytic substrate-selective, p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof | Paul S. Shapiro, Jeffrey D. HASDAY | 2022-06-14 |
| 11078171 | Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors | Paul S. Shapiro, Jeffrey D. HASDAY, Steven Fletcher | 2021-08-03 |
| 10961214 | Small molecule lipid II inhibitors | Erik de Leeuw, Steven Fletcher, Jamal Chauhan | 2021-03-30 |
| 10941114 | Small molecule lipid II inhibitors | Erik de Leeuw, Steven Fletcher, Jamal Chauhan | 2021-03-09 |
| 10002228 | Method for binding site identification by molecular dynamics simulation (silcs: site identification by ligand competitive saturation) | Olgun Guvench | 2018-06-19 |
| 9943506 | BCL6 inhibitors as anticancer agents | Ari M. Melnick, Leandro Carlos A. Cerchietti, Mariano G. Cardenas, Fengtian Xue | 2018-04-17 |
| 9757375 | Compounds that inhibit human DNA ligases and methods of treating cancer | Alan Edward Tomkinson, Helen Xi Chen, Barbara Dziegielewska, Shijun Zhong, Gerald M. Wilson | 2017-09-12 |
| 9701627 | LRRK2 GTP binding inhibitors for treatment of Parkinson's disease and neuroinflammatory disorders | Wanli Smith, Fengtian Xue | 2017-07-11 |
| 9422302 | Mixed μ agonist/ δ antagonist opioid analgesics with reduced tolerance liabilities and uses thereof | Andrew Coop, Rae Matsumoto | 2016-08-23 |
| 9351963 | Defensin-like molecules as novel antimicrobial agents | Erik de Leeuw | 2016-05-31 |
| 9115122 | Non-ATP dependent inhibitors of extracellular signal-regulated kinase (ERK) | Paul S. Shapiro, Steven Fletcher | 2015-08-25 |
| 9073896 | Compounds that inhibit human DNA ligases and methods of treating cancer | Alan Edward Tomkinson, Helen Xi Chen, Barbara Dziegielewska, Shijun Zhong, Gerald M. Wilson | 2015-07-07 |
| 8796323 | Defensin-like molecules as novel antimicrobial agents | Erik de Leeuw | 2014-08-05 |
| 8785499 | Targeting NAD biosynthesis in bacterial pathogens | Hong Zhang, Andrei Osterman, Rohit Kolhatkar | 2014-07-22 |
| 8673913 | SHP-2 phosphatase inhibitor | Cheng Qu, Wen-Mei Yu, Olgun Guvench | 2014-03-18 |
| 8476273 | Small molecule inhibitors of Lck SH2 domain binding | Jun Hayashi, Younus Mia, Guanjun Xia | 2013-07-02 |
| 8445537 | Compounds that inhibit human DNA ligases and methods of treating cancer | Alan Edward Tomkinson, Xi Chen, Barbara Dziegielewska, Shijun Zhong, Gerald M. Wilson | 2013-05-21 |
| 8338464 | Small molecule inhibitors of BCL6 | Ari M. Melnick, Gilbert Privé | 2012-12-25 |